Investors Overview

Press Release

View printer-friendly version

BD Board Declares Dividend

FRANKLIN LAKES, N.J., Nov. 25, 2014 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.60 cents per common share, an increase of about 10.0 percent from the previous quarter.  The dividend will be payable on December 31, 2014 to holders of record on December 10, 2014. The indicated annual dividend rate for fiscal year 2015 is $2.40 per share.

"We have built a strong foundation for growth and we look to the future with confidence," said Vincent A. Forlenza, Chairman, CEO and President. "This is the forty-third consecutive fiscal year in which we have raised our dividend. This increase reflects our confidence in our long-term outlook, as well as our ongoing commitment of returning value to our shareholders."

About BD

BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research. We have more than 30,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. For more information, please visit www.bd.com.

Contact:
Ed Cook, Corporate Communications – 201-847-7176
Monique Dolecki, Investor Relations – 201-847-5378

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bd-board-declares-dividend-300000950.html

SOURCE BD (Becton, Dickinson and Company)

Investor Highlights

Placeholder

Meet Jonathan

Moments after crossing the finish line of a half marathon, Jonathan went into cardiac arrest due to a congenital defect in his artery.
Placeholder

Drone Delivery Capabilities

See how BD and WeRobotics worked to advance drones for healthcare in the Peruvian Amazon
Placeholder

AMR Leadership

BD solutions to combat antimicrobial resistance

© 2019 BD. All rights reserved. Unless otherwise noted, BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company.